The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

As com­pa­nies dump mon­ey in­to man­u­fac­tur­ing, where will they find the trained work­ers to staff the lines?

4 years ago

Aa­van­tiBio lands man­u­fac­tur­ing part­ner in Friedre­ich's Atax­ia pro­gram; NC Re­search Tri­an­gle lands an­oth­er CD­MO

4 years ago
R&D

A Bel­gian man­u­fac­tur­er looks to pit its freeze dry­ing process against mR­NA — and be­yond

4 years ago
R&D

As the mR­NA push con­tin­ues, Sam­sung will ex­pand its drug sub­stance man­u­fac­tur­ing at South Ko­re­an hub

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Af­ter Emer­gent dis­as­ter, As­traZeneca in talks to move to Catal­ent plant — re­port; Sinopharm says it has ca­pac­i­ty to pro­duce 5B vac­cines

4 years ago
R&D

Mod­er­na bags an­oth­er US CD­MO to help with fill-fin­ish work for its vac­cine amid boost­er push

4 years ago
Outsourcing

The man­u­fac­tur­ing hold at Emer­gen­t's Bal­ti­more Bayview plant could be com­ing to an end — re­port

4 years ago
Coronavirus

CD­MO Ter­gus cuts the rib­bon on Durham plant, lat­est in a line of com­pa­nies pack­ing in­to the emerg­ing NC hub

4 years ago

Bio­gen adds key man­u­fac­tur­ing plant to its po­ten­tial­ly quixot­ic ad­u­canum­ab launch plan

4 years ago

Q&A: Amid an M&A flur­ry at Charles Riv­er, long­time ex­ec Bir­git Gir­shick dis­cuss­es how Covid-19 has changed the game

4 years ago
People

Covid-19 man­u­fac­tur­ing roundup: WHO let­ter out­lines re­boot of IP shar­ing pro­gram; In­dia backs down on do­mes­ti­cal­ly-pro­duced vac­cine tri­al

4 years ago
Coronavirus

Eli Lil­ly's much-ma­ligned Branch­burg plant earns a fed­er­al sub­poe­na amid whistle­blow­er claims tied to Covid-19 work

4 years ago
Coronavirus

Mer­ck KGaA draws the cur­tain on newest lipid nanopar­ti­cle for mR­NA vac­cines, tur­bocharg­ing its an­nu­al ca­pac­i­ty

4 years ago
Coronavirus

A CRO look­ing to build its man­u­fac­tur­ing side busi­ness has a new par­ent af­ter Keen­sight snaps up ma­jor­i­ty stake

4 years ago
Deals
Outsourcing

Chi­nese on­col­o­gy play­er is the lat­est to join the North Car­oli­na man­u­fac­tur­ing par­ty with 2 new plants in the off­ing

4 years ago

Re­silience has caught the eye of the Cana­di­an gov­ern­ment, which will in­vest $163M to boost mR­NA pro­duc­tion

4 years ago
Coronavirus

Af­ter record-break­ing de­mand for in­jecta­bles, BD to ex­pand in Spain with $200M Zaragoza plant

4 years ago
Coronavirus

No­var­tis' San­doz reshuf­fles an­tibi­ot­ic sup­ply chain in EU as field faces a short­age of in­vest­ment

4 years ago

Covid-19 man­u­fac­tur­ing re­port: Ire­land will pro­duce mR­NA com­po­nent for Pfiz­er's vac­cine; Lon­za re­cruits fed­er­al em­ploy­ees for rapid ramp-up

4 years ago
Coronavirus

Ther­mo Fish­er part­ners with UCSF to pro­vide a one-stop shop for ear­ly biotech man­u­fac­tur­ing

4 years ago

Charles Riv­er keeps adding on to its CD­MO arm, snatch­ing up a vi­ral vec­tor play­er for a tidy $350M

4 years ago
Deals

Vac­cine mak­er North­west Bio claims it's in the home­stretch for its man­u­fac­tur­ing ex­pan­sion in the UK

4 years ago

PerkinElmer hits the check­book again, this time dol­ing out $260M for next-gen ther­a­py bioser­vices firm

4 years ago
Deals

Mod­er­na taps in­to Aus­tralia with Covid-19 boost­er deal and the po­ten­tial for lo­cal man­u­fac­tur­ing

4 years ago
Coronavirus
First page Previous page 70717273747576 Next page Last page
A service from the Financial Times